Last Month in Oncology with Dr. Bishal Gyawali: April 2019

By BISHAL GYAWALI, MD Keynote speech on the JAVELIN not going far enough to improve survival The treatment landscape for metastatic renal-cell carcinoma has changed dramatically with the introduction of immunotherapies. Unfortunately though, we are promoting combinations over single agents without having much idea of added benefit of each drug. This is an important issue… Read More »

Teva Pharm CFO says company did not conspire to fix prices

FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference to discuss the company’s 2019 outlooks in Tel Aviv, Israel, February 19, 2019. REUTERS/Amir Cohen/File Photo JERUSALEM (Reuters) – Teva Pharmaceutical Industries’ chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing… Read More »